OS-027 A prospective, randomized, double-blind, placebo-controlled, phase III, multicenter study to evaluate the immunogenicity and safety of recombinant hepatitis-e vaccine in healthy adults & adolescents

View at publisher
Authors: Premashis Kar, Ayush Jasrotia, Nikhil Nagre, Jata Shankar Kumar
Cited by: 1

Fields of Study & Subjects

Hepatitis Viruses Studies and Epidemiology Hepatitis B Virus Studies Liver Diseases and Immunity

Publication details

Journal / source
Journal of Hepatology
Publisher
Elsevier BV
Volume
84
Pages
S24–S24
Publication date
1 May 2026
Language
EN